Welcome to Our Global Laboratory


This means you get reliable and harmonized data, allowing you to make real-time decisions on your study trends.
Affiliate Lab
Integration of this affiliate lab into the Quintiles Central Laboratory network is facilitated by our significant clinical presence in Buenos Aires. Our dedicated senior scientists work in close collaboration with the lab's staff to establish and control technical consistency with quality standards. The Buenos Aires lab serves not only Argentina, but also Chile and Peru as needed when trials involve significant Latin American populations. With a broad test menu and complete laboratory offering, we help you get consistent quality data and results in Latin America.
It also handles clinical trial specimens in the course of trials managed by Quintiles Central Laboratory Services.
Affiliate Lab
Since 1998 we have partnered with Diagnosticos da America to offer laboratory services in Latin America. Through uniform instrumentation and our global standard operating procedures (SOPs), we provide you with consistent and harmonized data comparable across our network of wholly owned and affiliate labs, making it easier for you to compare your laboratory data across sites.
What began in 2003 as a partnership with Peking Union Medical College Hospital has now grown into a 17,000-square-foot downtown location with a state-of-the-art central lab facility. Our services here include digital pathology, a smart solution to regulatory restrictions against exporting tissue samples.
Since opening in early 2007, our central laboratory in Mumbai has provided the quality, flexibility and speed needed to help run efficient clinical trials. Harmonized with our global network of central labs, we ensure consistent data through uniform instrumentation and standardized SOPs. So you can gain access to patient populations anywhere in India, knowing your data is accurate and comparable.
Affiliate lab
Our Tokyo facility is staffed by our own highly trained technicians embedded within the Medca Japan laboratory. We can assure consistency with our global practices for accessioning, project management support, data capture, and specimen management and storage to help you make solid decisions on trends with your studies conducted in Japan.
Offering laboratory services in Europe since 1995, we expanded our capabilities by upgrading our facilities in 2009, doubling our capacity. We now bring under one roof our clinical and laboratory services, including assay development services. Now you have greater control of the entire clinical development process with consistent, global standard operating procedures and quality data.
In 1995 we chose Singapore as our first Asian office, and established the central laboratory there in 1998. The hub for the Asia Pacific region, Singapore is an ideal location with all the major logistics capabilities for a successful central laboratory operation delivering better logistics management and quicker sample analysis turnaround to you. Following our SOPs and global quality assurance standards, we enable you to pursue large-scale Phase II and III studies throughout Asia, without compromising data integrity.
Quintiles has had an established presence in South Africa since 1999, and our central laboratory in Pretoria is wholly owned and co-located with our clinical operations offices. So we can serve as your reliable ally for clinical trials not only in South Africa but also across the entire African continent. Because we have greater control over every step of the process, choosing Quintiles ensures uniform instrumentation and SOPs, so that results from a patient in South Africa are harmonized — directly comparable — to those from a patient anywhere else on the globe. The result? You can better monitor trends from patient data and make better informed decisions on that data.
With operations in the US since 1991 through our Central Laboratory in Atlanta, we offer you a broad test menu and follow rigorous quality assurance procedures to make certain your data is harmonized to help you make decisions faster. With the upgrade of our Atlanta facility in 2008 and the acquisition of Chicago-based Targeted Molecular Diagnostics in 2008, we expanded our capabilities. Now we can offer cell-, fluid- and tissue-based biomarker assay development services to help you better understand how your compounds work and in which populations they're most likely to perform best.